Background
Kamaria C. Cayton Vaught, M.D. is a reproductive endocrinology and infertility specialist in the Baltimore area who specializes in the management of disorders related to infertility and the endocrinopathy of female reproductive stages. She has undergone training in the management and evaluation of reproductive disorders such as male and female infertility, PCOS, endometriosis, premature ovarian insufficiency, recurrent pregnancy loss, and advanced surgical techniques in hysteroscopy and laparoscopy. In addition, her unique training also includes genetic counseling, genetic data analysis and interpretation, and preimplantation genetic testing. Dr. Cayton Vaught treats patients with a wide range of conditions, including uterine fibroids, endometriosis and recurrent pregnancy loss at the Johns Hopkins Fertility Center.
Dr. Cayton Vaught completed her combined undergraduate and medical doctor degree at the University of Missouri-Kansas City School of Medicine. She then completed her residency at the University of Maryland School of Medicine, followed by postdoctoral fellowships in reproductive sciences and reproductive endocrinology, infertility, medical genetics and genomics (REI/MGG) at the Johns Hopkins University School of Medicine. Dr. Cayton Vaught is the first fellow to complete the combined REI/MGG program at Johns Hopkins and one of only a handful of fellowship-trained REI geneticist in the United States. While in fellowship she received the American Society of Reproductive Medicine In-training award for Research, an award in recognition of outstanding research conducted by individuals who are in training. As a senior fellow, Dr. Cayton Vaught went on to be an inaugural Women’s Reproductive Health Research (WRHR) scholar at Johns Hopkins showing her true dedication and passion to women’s health research.
Dr. Cayton Vaught’s research interests include the genetic basis of reproductive function, recurrent pregnancy loss and infertility. Her current focus is utilizing genome editing techniques, such as CRISPR-Cas9, to further understand the genes and regulatory pathways that are required for granulosa cells to respond to gonadotropins. Recently she was named a recipient of the Society of Reproductive Investigation Bayer Innovation Grant to further study hormonal signaling in granulosa cells.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.